trial

Financial Incentives to Improve Medication Adherence

NCTId NCT04191876
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 25 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2020-05-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2019-11-01
Primary completion
2020-05-30
Eligibility
ALL · 18 Years · 80 Years

Interventions & indications

Drugs
Wellth - Financial Incentives

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
25
Phase
NA
Primary Completion Date
2020-05-30
Status
COMPLETED
relationships
The graph out of here
drug
Wellth - Financial Incentives
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Medication Adherence
indication